Skip to main content
. 2017 Jun 11;2017:3296294. doi: 10.1155/2017/3296294

Figure 5.

Figure 5

Sestrins inhibit ROS generation and mTOR activation and augment AMPK signaling and antioxidant levels in cells. These modulatory effects of Sestrins make them an attractive therapeutic target and a biomarker in various diseases such as neurodegenerative diseases, metabolic disorders, cardiovascular diseases, and cancer. AMPK: AMP-dependent protein kinase; mTOR: mammalian target of rapamycin; ROS: reactive oxygen species.